ID   L1210/CPA
AC   CVCL_4Y57
DR   Wikidata; Q54900957
RX   PubMed=6354439;
CC   Selected for resistance to: ChEBI; CHEBI:4027; Cyclophosphamide (CP; Endoxan).
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from sampling site: Ascites.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-07-20; Version: 6
//
RX   PubMed=6354439;
RA   Schabel F.M. Jr., Skipper H.E., Trader M.W., Laster W.R. Jr.,
RA   Griswold D.P. Jr., Corbett T.H.;
RT   "Establishment of cross-resistance profiles for new agents.";
RL   Cancer Treat. Rep. 67:905-922(1983).
//